Literature DB >> 20450485

Structural disorder in the HIV-1 Vif protein and interaction-dependent gain of structure.

Tali H Reingewertz1, Deborah E Shalev, Assaf Friedler.   

Abstract

The HIV-1 Vif protein (192 residues) is required for HIV-1 infection of many target cells. Vif overcomes the anti-viral cellular defense by antagonizing the cellular cytosine deaminase APOBEC-3G through impairing APOBEC-3G production, inhibiting its enzymatic activity and targeting it for degradation. Vif interacts with several viral and cellular molecules, particularly via its C-terminal domain (residues 100-192). The structure of full-length Vif has not yet been determined. The structure of Vif and its domains was studied using computational and experimental methods. Computational predictions resulted in two suggested homology models for the full length protein. Experimental studies have shown that the Vif C-terminal domain is mainly unstructured. Residues 108-139 have mainly random coil conformation in the unbound state. This region includes an HCCH Zn(2+)-binding motif that also mediates Vif binding to Cul5, a protein in the E3 ubiquitin ligase complex. The C-terminal domain residues 141-192, which mediate interactions with both ElonginC and Cul5, are intrinsically disordered. This region also includes several phosphorylation sites and regions associated with the ability of Vif to undergo self-oligomerization. The unstructured nature of these regions enables them to interact with several ligands, and probably adopt various conformations as is typical for intrinsically disordered proteins. This was demonstrated by a conformational change induced by Zn(2+) binding to the HCCH motif and a conformational change that the C-terminal domain underwent in the presence of dodecylphosphocholine. The only available crystal structure of Vif includes residues 140-155, which are helical when bound to the ElonginBC complex. Overall, empirical structures, predictions and other experimental data for Vif did not always indicate the same degree or type of structure for any given region. This ambiguity is likely to be the tenet of structurally unfolded proteins, which have the propensity to adopt a multitude of biologically relevant and active conformations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20450485     DOI: 10.2174/092986610791498876

Source DB:  PubMed          Journal:  Protein Pept Lett        ISSN: 0929-8665            Impact factor:   1.890


  14 in total

1.  Molecular insight into the conformational dynamics of the Elongin BC complex and its interaction with HIV-1 Vif.

Authors:  Sean R Marcsisin; John R Engen
Journal:  J Mol Biol       Date:  2010-08-20       Impact factor: 5.469

2.  Conformational Dynamics of the HIV-Vif Protein Complex.

Authors:  K Aurelia Ball; Lieza M Chan; David J Stanley; Elise Tierney; Sampriti Thapa; Hai M Ta; Lily Burton; Jennifer M Binning; Matthew P Jacobson; John D Gross
Journal:  Biophys J       Date:  2019-03-23       Impact factor: 4.033

3.  High-speed atomic force microscopy directly visualizes conformational dynamics of the HIV Vif protein in complex with three host proteins.

Authors:  Yangang Pan; Luda S Shlyakhtenko; Yuri L Lyubchenko
Journal:  J Biol Chem       Date:  2020-06-24       Impact factor: 5.157

4.  Characterization of RNA binding and chaperoning activities of HIV-1 Vif protein. Importance of the C-terminal unstructured tail.

Authors:  Dona Sleiman; Serena Bernacchi; Santiago Xavier Guerrero; Franck Brachet; Valéry Larue; Jean-Christophe Paillart; Carine Tisne
Journal:  RNA Biol       Date:  2014-07-22       Impact factor: 4.652

5.  Dispersed and conserved hydrophobic residues of HIV-1 Vif are essential for CBFβ recruitment and A3G suppression.

Authors:  Xiaohong Zhou; Xue Han; Ke Zhao; Juan Du; Sean L Evans; Hong Wang; Peng Li; Wenwen Zheng; Yajuan Rui; Jian Kang; Xiao-Fang Yu
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

Review 6.  Protein intrinsic disorder as a flexible armor and a weapon of HIV-1.

Authors:  Bin Xue; Marcin J Mizianty; Lukasz Kurgan; Vladimir N Uversky
Journal:  Cell Mol Life Sci       Date:  2011-10-28       Impact factor: 9.261

7.  Multifaceted counter-APOBEC3G mechanisms employed by HIV-1 Vif.

Authors:  Elena Britan-Rosich; Roni Nowarski; Moshe Kotler
Journal:  J Mol Biol       Date:  2011-07-29       Impact factor: 5.469

8.  Mapping the Vif-A3G interaction using peptide arrays: a basis for anti-HIV lead peptides.

Authors:  Tali H Reingewertz; Elena Britan-Rosich; Shahar Rotem-Bamberger; Mathias Viard; Amy Jacobs; Abigail Miller; Ji Youn Lee; Jeeseong Hwang; Robert Blumenthal; Moshe Kotler; Assaf Friedler
Journal:  Bioorg Med Chem       Date:  2013-03-14       Impact factor: 3.641

9.  Crystal structure of the DNA cytosine deaminase APOBEC3F: the catalytically active and HIV-1 Vif-binding domain.

Authors:  Markus-Frederik Bohn; Shivender M D Shandilya; John S Albin; Takahide Kouno; Brett D Anderson; Rebecca M McDougle; Michael A Carpenter; Anurag Rathore; Leah Evans; Ahkillah N Davis; Jingying Zhang; Yongjian Lu; Mohan Somasundaran; Hiroshi Matsuo; Reuben S Harris; Celia A Schiffer
Journal:  Structure       Date:  2013-05-16       Impact factor: 5.006

10.  Molecular dynamics simulation in virus research.

Authors:  Hirotaka Ode; Masaaki Nakashima; Shingo Kitamura; Wataru Sugiura; Hironori Sato
Journal:  Front Microbiol       Date:  2012-07-19       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.